Group | n | Mean ± SE b | Difference from placebo group b (95% CI) | P- value | |
---|---|---|---|---|---|
FAS-LOCF | Placebo | 44 | 0.6 ± 0.5 | – | – |
5 mg | 43 | 1.4 ± 0.5 | 0.8 (−0.5, 2.1) | 0.232 | |
10 mg | 49 | 2.2 ± 0.4 | 1.6 (0.3, 2.8) | 0.016c | |
FAS-OC | Placebo | 37 | 1.0 ± 0.5 | – | – |
5 mg | 32 | 2.2 ± 0.5 | 1.2 (−0.2, 2.7) | 0.083 | |
10 mg | 43 | 2.6 ± 0.4 | 1.6 (0.3, 2.9) | 0.014c | |
PPS-LOCF | Placebo | 40 | 0.5 ± 0.5 | – | – |
5 mg | 34 | 2.1 ± 0.5 | 1.6 (0.2, 2.9) | 0.025c | |
10 mg | 45 | 2.4 ± 0.4 | 1.9 (0.6, 3.2) | 0.004c |